首页> 美国卫生研究院文献>Chinese Medical Journal >Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center Randomized Double-blind Double-dummy and Parallel Controlled Trial
【2h】

Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center Randomized Double-blind Double-dummy and Parallel Controlled Trial

机译:壮骨关节胶囊联合塞来昔布治疗膝骨性关节炎的疗效和安全性:多中心随机双盲双模拟和平行对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Knee osteoarthritis (KOA) is a chronic joint disease that manifests as knee pain as well as different degrees of lower limb swelling, stiffness, and movement disorders. The therapeutic goal is to alleviate or eliminate pain, correct deformities, improve or restore joint functions, and improve the quality of life. This study aimed to evaluate the efficacy and safety of Zhuanggu joint capsules combined with celecoxib and the benefit of treatment with Zhuanggu alone for KOA.
机译:背景:膝关节骨关节炎(KOA)是一种慢性关节疾病,表现为膝盖疼痛以及不同程度的下肢肿胀,僵硬和运动障碍。治疗目标是减轻或消除疼痛,纠正畸形,改善或恢复关节功能并改善生活质量。本研究旨在评估壮古关节胶囊联合塞来昔布的疗效和安全性,以及单独使用壮古联合治疗KOA的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号